当前位置: 首页 >> 检索结果
124. Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
作者: Fasiha Kanwal.;Fernando Bril.;Vincent Wai-Sun Wong.;Leon A Adams.;Kim Pfotenhauer.;Neil Skolnik.;Eugene E Wright.;Robert H Eckel.;Mazen Noureddin.;Rohit Loomba.;Alina M Allen.;Meena B Bansal.;Kyler M Godwin.;Hashem B El-Serag.;Jay H Shubrook.
来源: Gastroenterology. 2026年
The American Gastroenterological Association gathered a group of interdisciplinary experts to develop an updated Clinical Care Pathway on how to best screen for, diagnose, and treat metabolic dysfunction-associated steatotic liver disease. The complementary clinical application was also updated to reflect the changes in the clinical guidance: MASLD/MASH Clinical Care Pathway mobile application at gastro.org/MASLD.
125. Routine magnifying endoscopy mode improved the diagnostic efficacy of opportunistic screening for early upper gastrointestinal neoplasms: a prospective, randomized controlled study.
作者: Yi Li.;Min Li.;Lili Ren.;Fucheng Zhang.;Jinling Cheng.;Daocong Ren.;Pengcheng Guo.;Jiayi Wang.;Zhi Wei.
来源: BMC Gastroenterol. 2026年 126. Systematic review of prognostic value of cardiorespiratory fitness in patients with cirrhosis.
作者: Alexis Couret.;Fabrice Rannou.;Bruno Pereira.;Martine Duclos.;James A King.;Sebastien Dharancy.;Remi Nevière.;Delphine Weil-Verhoeven.;Gaël Ennequin.;Armand Abergel.
来源: BMC Gastroenterol. 2026年
Cirrhosis is associated with significant risk of comorbidity and early mortality. Low physical function is common in patients with cirrhosis and could predict prognosis. Cardiorespiratory fitness (CRF), determined by maximal exercise with gas exchange measurement, has proven to predict the risk of mortality and disability in other chronic diseases. In patients with cirrhosis, it could help to inform prognostic stratification to improve care and management in clinical practice. This systematic review aims to determine the association between CRF (VO2Peak, percentage of predicted VO2Peak, Anaerobic Threshold (AT)) and mortality prediction, as well as morbidity prediction in cirrhosis.
128. Clinical Validation of a Simulation-Based Mastery Learning Curriculum for Colonoscopy and Polypectomy in Practicing Gastroenterologists.
作者: Srinadh Komanduri.;Elaine R Cohen.;Ronak V Patel.; .;Diane B Wayne.;Kenzie A Cameron.;Jeffrey H Barsuk.
来源: Gastroenterology. 2026年 129. High-intensity hydrophilic versus lipophilic statins in patients with primary biliary cholangitis: a multi-institutional analysis.
作者: Hussam Kawas.;Mohammad Alabbas.;Mohamad-Noor Abu-Hammour.;Barish Eren.;Walid Hazem.;Omar T Sims.;Dian-Jung Chiang.
来源: BMC Gastroenterol. 2026年 131. Automated glucose control systems in post-pancreatectomy diabetes: systematic review of clinical efficacy and nursing care implications.
作者: Chiara G Alaimo.;Filippo Bianchi.;Stefano Mancin.;Bianca Fidato.;Daniela Cattani.;Alessandra Valsecchi.;Cristina Chiari.;Giovanni Cangelosi.;Mauro Parozzi.;Sarah Scollo.;Simone Cosmai.;Diego Lopane.;Beatrice Mazzoleni.
来源: Minerva Gastroenterol (Torino). 2026年
Post-pancreatectomy diabetes (type 3c diabetes) is a frequent consequence of pancreatic cancer surgery and is characterized by extreme glycemic variability, high risk of severe hypoglycemia, and a substantial impact on quality of life and nursing workload. Technological solutions such as continuous glucose monitoring (CGM) and closed-loop insulin delivery may help address these challenges.
132. Prevalence and Consequences of APC Mosaicism in Patients With Colorectal Adenomas.
作者: Diantha Terlouw.;Manon Suerink.;Yentl Buitelaar.;Monique E van Leerdam.;Frederik J Hes.;Demi van Egmond.;Dina Ruano.;Anja Wagner.;Floris H Groenendijk.;Isabelle C Meijssen.;Eline Overwater.;Sanne W Bajwa-Ten Broeke.;Arjen R Mensenkamp.;Iris D Nagtegaal.;Carli M Tops.;Alexandra M J Langers.;Tom van Wezel.;Hans Morreau.;Maartje Nielsen.
来源: Gastroenterology. 2026年
A substantial proportion of patients with adenomatous polyposis have no germline pathogenic variant in APC. The aim of this study was to determine the prevalence of APC mosaicism in these patients with unexplained polyposis and to draft guidelines for APC mosaicism testing and surveillance.
133. Perturbations of Diet and Gut Signatures Persist During Remission in Crohn's Disease Despite Effective Immune Suppression.
作者: Tzipi Braun.;Nina Levhar.;Gilat Efroni.;Rotem Hadar.;David Jessula Levy.;Adi Talan Asher.;Kathleen Abu-Saad.;Arnona Ziv.;Sivan Ben-Avraham Shulman.;Adi Yahalom.;Efrat Glick Saar.;Bella Ungar.;Orit Picard.;Doron Yablecovitch.;Uri Kopylov.;Shai Bel.;Lee Denson.;Rami Eliakim.;Amnon Amir.;Shomron Ben-Horin.;Yael Haberman.
来源: Gastroenterology. 2026年
We aimed to identify dietary and gut signals during Crohn's disease (CD) remission that differ from the healthy state to highlight targets that may improve disease control and clearance.
134. Effect of a Computer-Aided Device for Detecting Gastric Neoplasms: A Multicenter, Randomized Controlled Trial.
作者: Zehua Dong.;Lianlian Wu.;Hongliu Du.;Xiao Tao.;Junxiao Wang.;Xiaoquan Zeng.;Yijie Zhu.;Shuzhe Tan.;Jiamin Wang.;Mei Deng.;Ting Yang.;Chen Chen.;Liming Wen.;Ying Li.;Congyao Jiang.;Chuang Tang.;Yulin Wang.;Zhifeng Zhao.;Qinghua Wang.;Haodong Yu.;Chaoyuan Chen.;Yaowei Ai.;Jie Pan.;Fengsong Chen.;Qiang Guo.;Xinli Mao.;Junhong Li.;Huifang Pang.;Jianyu Hao.;Yan Jiao.;Qizhi Wang.;Heng Zhang.;Shicai Ye.;Tong Dang.;Liangliang Yu.;Shan Hu.;Wei Zhou.;Yunchao Deng.;Yanxia Li.;Boru Chen.;Bing Xiao.;Jun Liu.;Jiamin Qin.;Ting Zhang.;Tong Bu.;Jiayi Shi.;Yumei Wang.;Hong Zhang.;Jiejun Lin.;Lei Jin.;Jianfeng Yu.;Bofu Tang.;Xia Tan.;Lilei Yu.;Honggang Yu.
来源: Gastroenterology. 2026年
Evidence about the effect of artificial intelligence (AI) on upper endoscopy in multicenter, randomized controlled trials is lacking. We aimed to explore whether AI can enhance gastric neoplasm detection.
135. Association Between Ultraprocessed Food Intake and Inflammatory Bowel Disease Risk: A Propensity-Matched Analysis With Monte Carlo Simulation From the Prospective Urban Rural Epidemiology Study.
作者: Neeraj Narula.;Emily C L Wong.;Sumathy Rangarajan.;Victoria Miller.;Paul Moayyedi.;Salim Yusuf.; .
来源: Gastroenterology. 2026年 138. The relationship between metabolic associated fatty liver disease and thyroid nodule: a cross-sectional study in China.
作者: Jun Xiao.;Shen Tian.;Juan Wu.;Zhou Xu.;Hao Li.;Shu Li.;Xin-Yu Liang.;Yu-Ling Chen.;Vishnu Prasad Adhikari.;Jing-Yu Song.;Chen-Yu Ma.;Rui-Ling She.;Zhao-Xing Li.;Liang Ran.;Ling-Quan Kong.
来源: BMC Gastroenterol. 2026年 139. Development of a liver stiffness measurement-based nomogram model to identify early CKD risk in patients with MAFLD.
作者: Dejin Huang.;Xiaoxuan Ma.;Qingchen Gao.;Xiaolong Shen.;Tongtong Yu.;Rongqi Wang.
来源: BMC Gastroenterol. 2026年26卷1期
To identify independent relevant factors for chronic kidney disease (CKD) in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) and to develop and validate a nomogram-based risk diagnostic model for MAFLD-CKD incorporating liver stiffness measurement (LSM).
140. Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized Trial.
作者: Jean-Frédéric Colombel.;Damian Garcia Olmo.;Szu-Ta Chen.;Zuzana Serclova.;David A Schwartz.;Steven D Wexner.;Julian Panés.;Chunyuan Wu.;Barbara Zhang.;Michael Song.;Caroline McKay.;Pradeep Nazarey.;Ekaterina Wright.;Laura Raffals.;Phillip Fleshner.
来源: Gastroenterology. 2026年
The ADMIRE CD trial demonstrated the efficacy and safety of darvadstrocel in patients with complex perianal fistulas from Europe and Israel. The efficacy and safety of darvadstrocel in an expanded patient population was investigated.
|